Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

mTOR Hyperactivation by Ablation of Tuberous Sclerosis Complex 2 in the Mouse Heart Induces Cardiac Dysfunction with the Increased Number of Small Mitochondria Mediated through the Down-Regulation of Autophagy

Open access

Abstract

Mammalian target of rapamycin complex 1 (mTORC1) is a key regulator of cell growth, proliferation and metabolism. mTORC1 regulates protein synthesis positively and autophagy negatively. Autophagy is a major system to manage bulk degradation and recycling of cytoplasmic components and organelles. Tuberous sclerosis complex (TSC) 1 and 2 form a heterodimeric complex and inactivate Ras homolog enriched in brain, resulting in inhibition of mTORC1. Here, we investigated the effects of hyperactivation of mTORC1 on cardiac function and structure using cardiac-specific TSC2-deficient (TSC2-/-) mice. TSC2-/- mice were born normally at the expected Mendelian ratio. However, the median life span of TSC2-/- mice was approximately 10 months and significantly shorter than that of control mice. TSC2-/- mice showed cardiac dysfunction and cardiomyocyte hypertrophy without considerable fibrosis, cell infiltration or apoptotic cardiomyocyte death. Ultrastructural analysis of TSC2-/- hearts revealed misalignment, aggregation and a decrease in the size and an increase in the number of mitochondria, but the mitochondrial function was maintained. Autophagic flux was inhibited, while the phosphorylation level of S6 or eukaryotic initiation factor 4E -binding protein 1, downstream of mTORC1, was increased. The upregulation of autophagic flux by trehalose treatment attenuated the cardiac phenotypes such as cardiac dysfunction and structural abnormalities of mitochondria in TSC2-/- hearts. The results suggest that autophagy via the TSC2-mTORC1 signaling pathway plays an important role in maintenance of cardiac function and mitochondrial quantity and size in the heart and could be a therapeutic target to maintain mitochondrial homeostasis in failing hearts.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0152628

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Development of cardiac dysfunction in cardiac-specific TSC2-deficient mice. (A): Western blot analysis of TSC proteins in adult cardiomyocytes isolated from 8-week-old TSC2+/+ and TSC2-/- mice. (B): Survival curve of the mice. (C): Physiological analysis of the mice at 4 months of age. BW, HW/BW, and Lung/BW indicate body weight, whole heart-to-body-weight ratio, and lung-to-body-weight ratio, respectively. (D): Echocardiographic analysis of the awake mice at 4 months of age. (E): Physiological analysis of the mice at 4 weeks of age. (F): Echocardiographic analysis of the awake mice at 4 weeks of age. Open and closed bars represent TSC2+/+ and TSC2-/- mice, respectively. Values represent the mean ± S.E.M. of data from 5–6 samples in (A), from 20 mice in (B), from 7–8 mice in (C), from 9 mice in (D), from 5–7 mice in (E) and from 3–5 mice in (F) in each group. *P < 0.05 versus corresponding control.
Fig 1 Development of cardiac dysfunction in cardiac-specific TSC2-deficient mice. (A): Western blot analysis of TSC proteins in adult cardiomyocytes isolated from 8-week-old TSC2+/+ and TSC2-/- mice. (B): Survival curve of the mice. (C): Physiological analysis of the mice at 4 months of age. BW, HW/BW, and Lung/BW indicate body weight, whole heart-to-body-weight ratio, and lung-to-body-weight ratio, respectively. (D): Echocardiographic analysis of the awake mice at 4 months of age. (E): Physiological analysis of the mice at 4 weeks of age. (F): Echocardiographic analysis of the awake mice at 4 weeks of age. Open and closed bars represent TSC2+/+ and TSC2-/- mice, respectively. Values represent the mean ± S.E.M. of data from 5–6 samples in (A), from 20 mice in (B), from 7–8 mice in (C), from 9 mice in (D), from 5–7 mice in (E) and from 3–5 mice in (F) in each group. *P < 0.05 versus corresponding control.CC BY · PubMed Central
Fig 2 Development of cardiac hypertrophy in TSC2-/- mice. The data at 4 months of age in (A) to (C), (E) and (G). The data at 4 weeks of age in (D), (F) and (H). (A): Haematoxylin and eosin (H&E)-stained heart sections. (B): Wheat germ agglutinin (WGA)-stained heart sections. (C) and (D): Cardiomyocyte cross-sectional area was measured by tracing the outline of 100 myocytes in each section. (E) and (F): Number of TUNEL-positive cardiomyocytes. (G) and (H): mRNA expressions of Nppa, Myh7 and Col1a2 were determined by quantitative RT-PCR. Data were normalized to the Gapdh content and are expressed as fold increase over levels in the TSC2+/+ group. Open and closed bars represent TSC2+/+ and TSC2-/- mice, respectively. Values represent the mean ± S.E.M. of data from 4 mice in (C) and (E), from 3 mice in (D) and (F), from 3–4 mice in (G) and from 4–5 mice in (H) in each group. *P < 0.05 versus control group. Scale bars, 50 micrometers.
Fig 2 Development of cardiac hypertrophy in TSC2-/- mice. The data at 4 months of age in (A) to (C), (E) and (G). The data at 4 weeks of age in (D), (F) and (H). (A): Haematoxylin and eosin (H&E)-stained heart sections. (B): Wheat germ agglutinin (WGA)-stained heart sections. (C) and (D): Cardiomyocyte cross-sectional area was measured by tracing the outline of 100 myocytes in each section. (E) and (F): Number of TUNEL-positive cardiomyocytes. (G) and (H): mRNA expressions of Nppa, Myh7 and Col1a2 were determined by quantitative RT-PCR. Data were normalized to the Gapdh content and are expressed as fold increase over levels in the TSC2+/+ group. Open and closed bars represent TSC2+/+ and TSC2-/- mice, respectively. Values represent the mean ± S.E.M. of data from 4 mice in (C) and (E), from 3 mice in (D) and (F), from 3–4 mice in (G) and from 4–5 mice in (H) in each group. *P < 0.05 versus control group. Scale bars, 50 micrometers.CC BY · PubMed Central
Fig 3 Upregulation of the mTORC1 signaling pathway in TSC2-/- hearts. The data at 4 months of age in (A) to (C). The data at 4 weeks of age in (D) to (F). (A) and (D): Western blot analysis of signaling proteins upstream or downstream of mTORC1 in the heart of TSC2+/+ or TSC2-/- mice. p-Akt, t-Akt, p-AMPK, t-AMPK, p-S6 and t-S6 indicate phosphorylated Akt, total Akt, phosphorylated AMPK, total AMPK, phosphorylated S6 and total S6, respectively. Data of phosphorylated proteins were normalized to corresponding total protein content, TSC1 and t-AMPK to alpha-tubulin and gamma-form to total 4E-BP1 (t-4E-BP1), respectively. (B) and (E): Western blot analyses of KDEL and ubiquitinated proteins. (C) and (F): Western blot analyses of LC3 and p62. Data were normalized to the alpha-tubulin protein. All data are expressed as fold increase over levels in the TSC2+/+ group. Open and closed bars represent TSC2+/+ and TSC2-/- mice, respectively. Values represent the mean ± S.E.M. of data from 3–7 mice in each group. *P < 0.05 versus corresponding control.
Fig 3 Upregulation of the mTORC1 signaling pathway in TSC2-/- hearts. The data at 4 months of age in (A) to (C). The data at 4 weeks of age in (D) to (F). (A) and (D): Western blot analysis of signaling proteins upstream or downstream of mTORC1 in the heart of TSC2+/+ or TSC2-/- mice. p-Akt, t-Akt, p-AMPK, t-AMPK, p-S6 and t-S6 indicate phosphorylated Akt, total Akt, phosphorylated AMPK, total AMPK, phosphorylated S6 and total S6, respectively. Data of phosphorylated proteins were normalized to corresponding total protein content, TSC1 and t-AMPK to alpha-tubulin and gamma-form to total 4E-BP1 (t-4E-BP1), respectively. (B) and (E): Western blot analyses of KDEL and ubiquitinated proteins. (C) and (F): Western blot analyses of LC3 and p62. Data were normalized to the alpha-tubulin protein. All data are expressed as fold increase over levels in the TSC2+/+ group. Open and closed bars represent TSC2+/+ and TSC2-/- mice, respectively. Values represent the mean ± S.E.M. of data from 3–7 mice in each group. *P < 0.05 versus corresponding control.CC BY · PubMed Central
Fig 4 Morphological abnormality in mitochondria of TSC2-/- hearts. The data at 4 months of age in (A) to (E). The data at 4 weeks of age in (F) to (I). (A) and (F): Electron micrographs of TSC2+/+ and TSC2-/- mouse hearts. Intramitochondrial structure is shown in the insets. (B) and (G): Quantitative analysis of mitochondria in size and number. (C) and (H): Western blot analysis of HNE proteins in the mitochondrial fraction isolated from the heart. VDAC is used as loading control. (D) and (I): Western blot analysis of proteins related to mitophagy. (E): Western blot analysis for mitochondrial proteins. Data were normalized to the VDAC or alpha-tubulin protein content and are expressed as fold increase over levels in the TSC2+/+ group. Open and closed bars represent TSC2+/+ and TSC2-/- mice, respectively. Values represent the mean ± S.E.M. of data from 3–5 mice in each group. *P < 0.05 versus corresponding control. Scale bars: 2 micrometers in (A); 1 micrometer in insets of (A).
Fig 4 Morphological abnormality in mitochondria of TSC2-/- hearts. The data at 4 months of age in (A) to (E). The data at 4 weeks of age in (F) to (I). (A) and (F): Electron micrographs of TSC2+/+ and TSC2-/- mouse hearts. Intramitochondrial structure is shown in the insets. (B) and (G): Quantitative analysis of mitochondria in size and number. (C) and (H): Western blot analysis of HNE proteins in the mitochondrial fraction isolated from the heart. VDAC is used as loading control. (D) and (I): Western blot analysis of proteins related to mitophagy. (E): Western blot analysis for mitochondrial proteins. Data were normalized to the VDAC or alpha-tubulin protein content and are expressed as fold increase over levels in the TSC2+/+ group. Open and closed bars represent TSC2+/+ and TSC2-/- mice, respectively. Values represent the mean ± S.E.M. of data from 3–5 mice in each group. *P < 0.05 versus corresponding control. Scale bars: 2 micrometers in (A); 1 micrometer in insets of (A).CC BY · PubMed Central
Fig 5 Biochemical analyses of mitochondrial function in TSC2-/- hearts at 4 weeks of age. (A): The activities of complex I + III and complex II + III in mitochondria isolated from the hearts. (B): The ATP content expressed as fold increase over levels in the TSC2+/+ group and ADP to ATP ratio (ADP/ATP) in the heart tissues. (C): mRNA expression of Pgc-1a was determined by quantitative RT-PCR. Data were normalized to the Gapdh content and are expressed as fold increase over levels in the TSC2+/+ group. Values represent the mean ± S.E.M. of data from 3–4 mice in each group. Open and closed bars represent TSC2+/+ and TSC2-/- mice, respectively. *P < 0.05 versus corresponding control.
Fig 5 Biochemical analyses of mitochondrial function in TSC2-/- hearts at 4 weeks of age. (A): The activities of complex I + III and complex II + III in mitochondria isolated from the hearts. (B): The ATP content expressed as fold increase over levels in the TSC2+/+ group and ADP to ATP ratio (ADP/ATP) in the heart tissues. (C): mRNA expression of Pgc-1a was determined by quantitative RT-PCR. Data were normalized to the Gapdh content and are expressed as fold increase over levels in the TSC2+/+ group. Values represent the mean ± S.E.M. of data from 3–4 mice in each group. Open and closed bars represent TSC2+/+ and TSC2-/- mice, respectively. *P < 0.05 versus corresponding control.CC BY · PubMed Central
Fig 6 Effects of trehalose treatment on cardiac phenotypes in TSC2-/- mice. (A): Western blot analysis for LC3 in trehalose-treated TSC2+/+ group. Data were normalized to alpha-tubulin protein content. White and light gray bars represent control TSC2+/+ mice and trehalose-treated TSC2+/+ mice, respectively. (B): Echocardiographic parameters of the awake TSC2-/- mice. (C): Physiological parameters of the TSC2-/- mice. BW, HW and HW/BW indicate body weight, whole heart weight and whole heart-to-body-weight ratio, respectively. (D): Western blot analysis for LC3 and p62. Data were normalized to alpha-tubulin protein content. All data are expressed as fold increase over levels in control TSC2-/- group. (E and F): Electron micrographs of the TSC2-/- hearts (E) and quantitative analyses of mitochondrial size and number (F). In (B) to (F), black and dark gray bars represent control TSC2-/- mice and trehalose-treated TSC2-/- mice, respectively. Values represent the mean ± S.E.M. of data from 3 to 5 mice in each group. *P < 0.05 versus control group. Scale bars: 2 micrometers.
Fig 6 Effects of trehalose treatment on cardiac phenotypes in TSC2-/- mice. (A): Western blot analysis for LC3 in trehalose-treated TSC2+/+ group. Data were normalized to alpha-tubulin protein content. White and light gray bars represent control TSC2+/+ mice and trehalose-treated TSC2+/+ mice, respectively. (B): Echocardiographic parameters of the awake TSC2-/- mice. (C): Physiological parameters of the TSC2-/- mice. BW, HW and HW/BW indicate body weight, whole heart weight and whole heart-to-body-weight ratio, respectively. (D): Western blot analysis for LC3 and p62. Data were normalized to alpha-tubulin protein content. All data are expressed as fold increase over levels in control TSC2-/- group. (E and F): Electron micrographs of the TSC2-/- hearts (E) and quantitative analyses of mitochondrial size and number (F). In (B) to (F), black and dark gray bars represent control TSC2-/- mice and trehalose-treated TSC2-/- mice, respectively. Values represent the mean ± S.E.M. of data from 3 to 5 mice in each group. *P < 0.05 versus control group. Scale bars: 2 micrometers.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 57 references

Cited by

See all 57

Metadata

Authors
Taneike, M., Nishida, K., Omiya, S., Zarrinpashneh, E., Misaka, T., Kitazume-Taneike, R., Austin, R., Takaoka, M., Yamaguchi, O., Gambello, M. J., Shah, A. M., & Otsu, K.
Affiliations
  • King's College London (GB)
  • The University of Osaka (JP)
  • Emory University (US)
Corresponding author
Otsu, Kinya
Venue
PLOS ONE
Published
2016-03-29
Volume
11
Issue
3
Pages
e0152628
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2324750755
Cited by
57
References
57
Citations by year
2025: 7 · 2024: 2 · 2023: 4 · 2022: 4 · 2021: 9 · 2020: 6 · 2019: 5 · 2018: 8 · 2017: 10 · 2016: 2
FWCI
7.82
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Research Portal (King's College London) (submittedVersion, cc-by)
Funders
  • British Heart Foundation (CH/11/3/29051, RG/11/12/29052, CH/11/3/29051, RG/11/12/29052)
  • King's College London
  • Medical Research Council (MR/K019031/1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords
tuberous sclerosis complex 2, mTORC1 hyperactivation, cardiac dysfunction, autophagy, mitochondrial homeostasis, cardiomyocyte hypertrophy, trehalose, S6 phosphorylation, eIF4E-binding protein 1, heart mitochondria, heart failure
MeSH terms
Mechanistic Target of Rapamycin Complex 1, Tuberous Sclerosis Complex 2 Protein, Animals, Autophagy, Enzyme Activation, Heart, Cardiomegaly, Mice, Inbred C57BL, Mitochondria, Heart, Organ Specificity, Phenotype, Protein Biosynthesis, Trehalose, Signal Transduction, Down-Regulation, Up-Regulation, Tumor Suppressor Proteins, Multiprotein Complexes, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: mTOR Hyperactivation by Ablation of Tuberous Sclerosis Complex 2 in the Mouse Heart Induces Cardiac Dysfunction with the Increased Number of Small Mitochondria Mediated through the Down-Regulation of Autophagy. https://app.cochat.ai/papers/10.1371/journal.pone.0152628
The paper
Taneike, M., Nishida, K., Omiya, S., Zarrinpashneh, E., Misaka, T., Kitazume-Taneike, R., Austin, R., Takaoka, M., Yamaguchi, O., Gambello, M. J., Shah, A. M., & Otsu, K. (2016). mTOR Hyperactivation by Ablation of Tuberous Sclerosis Complex 2 in the Mouse Heart Induces Cardiac Dysfunction with the Increased Number of Small Mitochondria Mediated through the Down-Regulation of Autophagy. PLOS ONE. https://doi.org/10.1371/journal.pone.0152628

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.